Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
for
Clear Cell Renal Cell Carcinoma,
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07037004
Phase2, Recruiting
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Peabody MA, Burlington MA, Livonia MI, Canton MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07383441
Phase3, Recruiting
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC),
Location: Boston MA, Sarasota FL, Grand Rapids MI, Nashville TN,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06784193
Phase1, Recruiting
Study on Magnetic Field Therapy to Improve Quality of Sleep and Reduction of Chronic Spine Pain
for
Back Pain, Neck Pain,
Location: Briarcliff Manor NY
Sponsor: Weintraub, Michael I., MD, FACP, FAAN
Sex: All
Age: 18 - 70+
Code: NCT00445133
Recruiting
Interested in new pancreatic cancer trials?
Get alerts for new trials in your area by subscribing now
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
for
Extensive-stage Small-cell Lung Cancer
Location: Rock Hill SC, Jacksonville FL, Atlanta GA, Lexington KY,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07459634
Phase2, Recruiting
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Tampa FL, Zion IL, Houston TX, Goodyear AZ, Duarte CA
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07594106
Phase1, Phase2, Recruiting
Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study
for
Stage II Lung Cancer, Lung Cancer, Non-small Cell Lung Cancer,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT07412041
Recruiting
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Lake Success NY, Buffalo NY, Sarasota FL,
Sponsor: InduPro, Inc.
Sex: All
Age: 18+
Code: NCT07602842
Phase1, Phase2, Recruiting
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Orange City FL, Clermont FL, Detroit MI, Atlanta GA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase1, Phase2, Recruiting
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
for
Cutaneous Squamous Cell Carcinoma, Skin Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT07426484
Recruiting
DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
for
Small-cell Lung Cancer, Small Cell Lung Cancer Extensive Stage
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT07545954
Phase1, Recruiting
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
for
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18+
Code: NCT06768905
Phase1, Phase2, Recruiting
Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)